| 标题 |
A Randomized Phase 2 Study of Daratumumab, Lenalidomide, Ixazomib, and Dexamethasone in Transplant-Ineligible/Deferred Patients with Newly Diagnosed Multiple Myeloma: Alliance Foundation Trial 41 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma, Myeloma & Leukemia 作者:Andrew Yee; Elizabeth O’Donnell; O. Nadeem; Garth Nelson; Tanya Wildes; et al 出版日期:2025-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)